Issue 168

09.10.2020

Europe
USA
Latam & Caribbean
APAC
Africa & Middle East

Highlights

 

AUSTRALIAN MEDICAL CANNABIS APPROVALS ARE RISING DESPITE COVID-19 IMPACT

 

Despite the impact of COVID-19 on the Australian healthcare system, approvals of medical cannabis are once more increasing, as 35,428 have now been recorded in 2020, more than double the number of approvals recorded in 2019.

 

This news comes at an important time for the Australian cannabis market, which has seen a number of positive developments in recent weeks.

 

For a full overview, read the latest feature from Prohibition Partners, here.

 

READ MORE

 

HIGHLIGHTS 

Europe

 

CBD: The Consumer Report

 

 

CBD has become one of the biggest disruptors of mainstream industries over the last decade, impacting sectors from pharma to food and wellness to cosmetics.

 

Already a multibillion-dollar opportunity globally, the market is expanding at an unprecedented rate but many small-scale operators, multinational FMCGs and investors are struggling to understand the attitudes and spending that will dictate the future of this rapidly burgeoning market.

 

CBD: The Consumer Report helps provide the latest regulatory information, consumer data and market projections to guide your business through this turbulent market.

 

Available now in print and digital.

USA

Prohibition Partners LIVE

 

 

Learn from over 100+ expert speakers, connect with thousands of delegates from across the globe and help shape the future of the cannabis market.

 

Join the conversation.

Canada

 

Latam & Caribbean

 

APAC

Africa & Middle East